All In MedTech

FDA Clearance Tracker · P200023

Zilver Vena Venous Self-Expanding Stent

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Oct 9, 2020 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Oct 9, 2020

Approved

Time to decision

179 days

Received Apr 13, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P200023
Device name
Zilver Vena Venous Self-Expanding Stent
Applicant location
Limerick
Received
Apr 13, 2020
Decided
Oct 9, 2020
Decision
Approved
Supplements
9 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code QAN

FDA's approval statement

As written in FDA's record.

Approval for improving luminal diameter in the iliofemoral veins for the treatment of symptomatic iliofemoral venous outflow obstruction.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code QAN. The earliest in FDA's data is P180037, decided Mar 13, 2019.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Cook Ireland, Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.